Richard C. Young & CO. LTD. Has $242,000 Holdings in Becton, Dickinson and Company (BDX)

Richard C. Young & CO. LTD. maintained its stake in shares of Becton, Dickinson and Company (NYSE:BDX) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,240 shares of the medical instruments supplier’s stock at the close of the 2nd quarter. Richard C. Young & CO. LTD.’s holdings in Becton, Dickinson and were worth $242,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Almanack Investment Partners LLC. acquired a new stake in shares of Becton, Dickinson and in the first quarter worth $105,000. Parkside Financial Bank & Trust lifted its position in Becton, Dickinson and by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock worth $116,000 after purchasing an additional 9 shares during the period. QCI Asset Management Inc. NY lifted its position in Becton, Dickinson and by 9.2% in the first quarter. QCI Asset Management Inc. NY now owns 710 shares of the medical instruments supplier’s stock worth $130,000 after purchasing an additional 60 shares during the period. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its position in Becton, Dickinson and by 55.8% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock worth $131,000 after purchasing an additional 240 shares during the period. Finally, Financial Architects Inc lifted its position in Becton, Dickinson and by 8.0% in the second quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock worth $142,000 after purchasing an additional 54 shares during the period. Institutional investors and hedge funds own 87.12% of the company’s stock.

In related news, insider Thomas E. Polen, Jr. sold 5,971 shares of the company’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $197.41, for a total transaction of $1,178,735.11. Following the completion of the sale, the insider now directly owns 12,861 shares in the company, valued at approximately $2,538,890.01. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Linda M. Tharby sold 4,695 shares of the company’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $200.48, for a total value of $941,253.60. Following the sale, the executive vice president now owns 18,670 shares of the company’s stock, valued at $3,742,961.60. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 75,904 shares of company stock valued at $15,242,688. 1.40% of the stock is owned by corporate insiders.

BDX has been the subject of several research reports. BidaskClub cut Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Bank of America Corporation reaffirmed a “buy” rating and issued a $225.00 target price (up from $200.00) on shares of Becton, Dickinson and in a research report on Friday, July 21st. Zacks Investment Research raised Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 target price for the company in a research report on Monday, July 17th. Stifel Nicolaus reaffirmed a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday, August 9th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and issued a $213.00 target price on shares of Becton, Dickinson and in a research report on Tuesday, September 12th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. Becton, Dickinson and currently has an average rating of “Buy” and an average price target of $200.93.

ILLEGAL ACTIVITY NOTICE: “Richard C. Young & CO. LTD. Has $242,000 Holdings in Becton, Dickinson and Company (BDX)” was first reported by Markets Daily and is owned by of Markets Daily. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://www.themarketsdaily.com/2017/10/12/richard-c-young-co-ltd-has-242000-holdings-in-becton-dickinson-and-company-bdx.html.

Becton, Dickinson and Company (NYSE BDX) opened at 197.51 on Thursday. Becton, Dickinson and Company has a one year low of $161.29 and a one year high of $206.63. The company has a market capitalization of $44.95 billion, a PE ratio of 57.20 and a beta of 1.05. The firm’s 50 day moving average price is $197.04 and its 200-day moving average price is $192.83.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings data on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The business had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.06 billion. During the same period in the prior year, the company earned $2.35 EPS. Becton, Dickinson and’s revenue for the quarter was down 5.1% on a year-over-year basis. Equities analysts forecast that Becton, Dickinson and Company will post $9.46 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 29th. Investors of record on Friday, September 8th were given a dividend of $0.73 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $2.92 annualized dividend and a dividend yield of 1.48%. Becton, Dickinson and’s dividend payout ratio is currently 83.43%.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply